We examined the production and secretion of IAPP in a β-cell line, MIN6, which is derived from an insulinoma obtained by targeted expression of the SV40 T-antigen gene in a transgenic mouse. RNA blot analysis revealed an abundance of IAPP and insulin II mRNA in the cells, findings comparable with those in the pancreas of a normal mouse. The presence of IAPP and insulin was confirmed immunohistochemically and by RIA. Analysis of the reverse-phase HPLC identified IAPP in cells with authentic mouse IAPP. Raising the glucose concentration from 5.6 to 25 mM failed to induce increments in IAPP and insulin II mRNAs. The cells secrete IAPP and insulin for short- and long-term incubations in response to concentration of glucose in the medium. These features resemble those of islet cells from normal animals. This β-cell line will aid in analyzing the regulation of IAPP gene expression and the mechanisms of IAPP biosynthesis and secretion.
Skip Nav Destination
Article navigation
Original Articles|
November 01 1992
Islet Amyloid Polypeptide/Amylin in Pancreatic β-Cell Line Derived From Transgenic Mouse Insulinoma
Azuma Kanatsuka;
Azuma Kanatsuka
Second Department of Internal Medicine, Chiba University School of Medicine
Chiba
Department of Disease-Related Gene Regulation Research (Sandoz), Faculty of Medicine, University of Tokyo
Tokyo
Institute for Medical Genetics, Kumamoto University Medical School
Kumamoto, Japan
Search for other works by this author on:
Hideichi Makino;
Hideichi Makino
Second Department of Internal Medicine, Chiba University School of Medicine
Chiba
Department of Disease-Related Gene Regulation Research (Sandoz), Faculty of Medicine, University of Tokyo
Tokyo
Institute for Medical Genetics, Kumamoto University Medical School
Kumamoto, Japan
Search for other works by this author on:
Takahide Yamaguchi;
Takahide Yamaguchi
Second Department of Internal Medicine, Chiba University School of Medicine
Chiba
Department of Disease-Related Gene Regulation Research (Sandoz), Faculty of Medicine, University of Tokyo
Tokyo
Institute for Medical Genetics, Kumamoto University Medical School
Kumamoto, Japan
Search for other works by this author on:
Haruhiko Ohsawa;
Haruhiko Ohsawa
Second Department of Internal Medicine, Chiba University School of Medicine
Chiba
Department of Disease-Related Gene Regulation Research (Sandoz), Faculty of Medicine, University of Tokyo
Tokyo
Institute for Medical Genetics, Kumamoto University Medical School
Kumamoto, Japan
Search for other works by this author on:
Yoshiharu Tokuyama;
Yoshiharu Tokuyama
Second Department of Internal Medicine, Chiba University School of Medicine
Chiba
Department of Disease-Related Gene Regulation Research (Sandoz), Faculty of Medicine, University of Tokyo
Tokyo
Institute for Medical Genetics, Kumamoto University Medical School
Kumamoto, Japan
Search for other works by this author on:
Takeo Saitoh;
Takeo Saitoh
Second Department of Internal Medicine, Chiba University School of Medicine
Chiba
Department of Disease-Related Gene Regulation Research (Sandoz), Faculty of Medicine, University of Tokyo
Tokyo
Institute for Medical Genetics, Kumamoto University Medical School
Kumamoto, Japan
Search for other works by this author on:
Ken-Ichi Yamamura;
Ken-Ichi Yamamura
Second Department of Internal Medicine, Chiba University School of Medicine
Chiba
Department of Disease-Related Gene Regulation Research (Sandoz), Faculty of Medicine, University of Tokyo
Tokyo
Institute for Medical Genetics, Kumamoto University Medical School
Kumamoto, Japan
Search for other works by this author on:
Jun-Ichi Miyazaki;
Jun-Ichi Miyazaki
Second Department of Internal Medicine, Chiba University School of Medicine
Chiba
Department of Disease-Related Gene Regulation Research (Sandoz), Faculty of Medicine, University of Tokyo
Tokyo
Institute for Medical Genetics, Kumamoto University Medical School
Kumamoto, Japan
Search for other works by this author on:
Sho Yoshida
Sho Yoshida
Second Department of Internal Medicine, Chiba University School of Medicine
Chiba
Department of Disease-Related Gene Regulation Research (Sandoz), Faculty of Medicine, University of Tokyo
Tokyo
Institute for Medical Genetics, Kumamoto University Medical School
Kumamoto, Japan
Search for other works by this author on:
All correspondence and reprint requests should be addressed to Azuma Kanatsuka, MD, Second Department of Internal Medicine, Chiba University School of Medicine, 1–8–1 Inohana, Chiba 280, Japan.
Diabetes 1992;41(11):1409–1414
Article history
Received:
November 20 1991
Revision Received:
May 21 1992
Accepted:
May 21 1992
PubMed:
1383068
Citation
Azuma Kanatsuka, Hideichi Makino, Takahide Yamaguchi, Haruhiko Ohsawa, Yoshiharu Tokuyama, Takeo Saitoh, Ken-Ichi Yamamura, Jun-Ichi Miyazaki, Sho Yoshida; Islet Amyloid Polypeptide/Amylin in Pancreatic β-Cell Line Derived From Transgenic Mouse Insulinoma. Diabetes 1 November 1992; 41 (11): 1409–1414. https://doi.org/10.2337/diab.41.11.1409
Download citation file:
60
Views